Pfizer (PFE)

Purchases of Investments

-$10.63B

TTM · Period ending: · USD

PFE logo

PFE Purchases of Investments

Latest reported-$10.63B
PFE TTM Purchases of Investments (-$89.60M → -$10.63B)
High-resolution chart · PNG

PFE purchases of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Purchases of Investments — Trailing twelve months (TTM) (USD)
Period endingPurchases of Investments (USD)
-10,633,000,000
-10,514,000,000
-14,650,000,000
-20,055,000,000
-17,790,000,000
-15,103,000,000
-10,313,000,000
-4,906,000,000
-11,442,000,000
-26,481,000,000
-31,178,000,000
-26,879,000,000
-36,464,000,000
-39,471,000,000
-42,189,000,000
-58,934,000,000
-57,849,000,000
-49,970,000,000
-47,613,000,000
-28,361,000,000
-13,731,000,000
-18,490,000,000
-14,402,000,000
-22,653,000,000
-20,108,000,000
-8,539,000,000
-7,036,000,000
-9,324,000,000
-13,468,000,000
-13,442,000,000
-13,474,000,000
-18,005,000,000
-18,268,000,000
-18,210,000,000
-18,133,000,000
-17,240,000,000
-20,124,000,000
-24,830,000,000
-28,186,000,000
-30,418,000,000
-28,791,000,000
-32,224,000,000
-38,123,000,000
-43,770,000,000
-56,715,000,000
-61,839,000,000
-61,672,000,000
-58,756,000,000
-57,169,000,000
-50,003,000,000
-58,058,000,000
-56,732,000,000
-49,748,000,000
-46,219,000,000
-35,163,000,000
-28,870,000,000
-25,451,000,000
-24,735,000,000
-22,491,000,000
-24,061,000,000
-19,591,000,000
-17,099,000,000
-14,851,000,000
13,290,000,000
-3,065,000,000
-24,089,000,000
-42,219,000,000
-80,602,000,000
-69,266,000,000
-55,082,000,000
-45,062,000,000
-36,710,000,000
-35,042,000,000
-31,432,000,000
-27,061,000,000
-20,227,000,000
-17,592,000,000
-15,346,000,000
-11,522,000,000
-20,544,000,000
-26,637,000,000
-26,293,000,000
-28,727,000,000
-23,817,000,000
-17,462,000,000
-19,157,000,000
-18,828,000,000
-12,620,000,000
-12,015,000,000
-11,219,000,000
-11,814,000,000
-12,558,000,000
-16,196,000,000
-16,717,000,000
-15,529,000,000
-21,067,000,000
-20,253,000,000
-19,664,000,000
-17,931,000,000
-12,086,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.